Rally #188-1-1880
Sekisui Diagnostics #1080
OSOM® Flu SARS-CoV-2 Combo Test (25/KT)
Rapid Test Combo (COVID‑19, Influenza A & B), Anterior Nasal Swab, Lateral Flow Immunochromatographic Assay, EUA Authorized, Internal Procedural Control, External Quality Control Available, Rx Only
Sekisui Diagnostics 2025 Promotion: Respiratory
Test for multiple respiratory infections with trusted OSOM® rapid tests!
Buy 6 kits for the price of 5 — mix and match from eligible OSOM® respiratory test kits.
Offer Valid Through September 30, 2025
See Details Below
- Delivers rapid results for COVID-19, Influenza A, and Influenza B in just 10 minutes from a single nasal swab.
- Capable of detecting a wide range of viral strains, including emerging variants like H5N1 avian flu.
- Includes built-in QC Inside® with two additional test sticks and buffer vials for internal quality control.
- Comes with pre-filled, ready-to-use buffer vials—no reconstitution or mixing required.
- Manufactured in the USA to ensure consistent quality and dependable availability.
This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Important Note:
- Restricted Product: Rx Only - Current Valid Medical License Required.
- Product is non-returnable; please make sure it is the right product before ordering.
- If put into refrigeration, do not freeze.
- For in vitro diagnostic use.
- For use under an Emergency Use Authorization (EUA) only.
- For more information on this product's EUA, please go to the EUA section below.
Rally # | 188-1-1880 |
Manufacturer # | 1080 |
Brand | OSOM® |
Manufacturer | Sekisui Diagnostics |
Country of Origin | United States |
Application | Respiratory Test Kit |
Number of Tests | 25 Tests |
Reading Type | Visual Read |
Sample Type | Anterior Nasal Swab Sample |
Test Format | Test Stick |
Test Kit Type | Rapid |
Test Method | Lateral Flow Immunochromatographic Assay |
Test Name | Flu A + B / SARS-CoV-2 Combo |
Time to Results | 10 Minute Results |
Storage Temperature | 15-30°C / 59-86°F |
Type | Positive Percent Agreement* | Negative Percent Agreement* |
SARS-CoV-2 | 87.0%** | 99.1% |
Flu A | 93.1% | 99.5% |
Flu B | 89.1% | 99.7% |
* Combined prospective clinical RT-PCR comparator study.
** Determined by a controlled analysis: Data shown is inclusion of 10% low positive samples by PCR. For all study cohort and performance at different low positive samples levels refer to IFU.
Configurations
Product ID | Description | Quantity |
1080 | OSOM FLU SARS-CoV-2 Combo Test | 25 Tests Per Kit |
1079 | OSOM FLU SARS-CoV-2 Combo Control Kit | 5 x Flu A/Flu B/SARS-CoV-2 Positive Control Swabs 5 x Flu A/Flu B/SARS-CoV-2 Negative Control Swabs |
Kit Content
- 25 - Sterile Nasal Swabs
- 27* - Test Sticks
- 27* - Extraction Buffer vials each containing 0.25 mL phosphate buffered salt solution (with 0.09% sodium azide as a preservative)
- 1 - Flu A / Flu B / SARS-CoV-2 Positive Control Swab (packaged with a desiccant tablet) coated with non-infectious recombinant influenza A, influenza B, and SARS-CoV-2 containing 0.05% sodium azide
- 1 - Flu A / Flu B / SARS-CoV-2 Negative Control Swab (packaged with a desiccant tablet) coated with nonviable Group C Streptococci containing 0.09% sodium azide
- 2 - Result Interpretation Cards
- 1 - Instructions for Use (IFU)
- 1 - Quick Reference Guide (QRG)
- 1 - Workstation
Documentation Links
Promotional Information
Sekisui Diagnostics 2025 Promotion: Respiratory
Test for multiple respiratory infections with trusted OSOM® rapid tests!Buy 6 kits for the price of 5 — mix and match from eligible OSOM® respiratory test kits.
Offer Valid Through September 30, 2025 OnlyEligible Products:
- OSOM® COVID-19 Antigen Rapid Test (cat. no. 1066-40)
- OSOM® Ultra Plus Flu A&B Test (cat. no. 1032)
- OSOM® RSV Test (cat. no. 1091)
- OSOM® Flu SARS-CoV-2 Combo Test (cat. no. 1080)
- Purchase any five kits (any combination) on a single invoice to qualify.
- To receive your kits, submit redemptions online at osompromos.com.
- All redemptions must be submitted by the deadline listed on the official promotion flyer (link below).
- Proof of purchase required.
- Customers will receive proof of purchase from Rally Inc. once their order has been processed.
- Sekisui Diagnostics is solely responsible for all aspects of the promotion, including eligibility determination, redemption processing, and fulfillment.
- Rally Inc. is not liable for the administration of the promotion, delays in fulfillment, or any changes to the offer.
- Rally Inc. does not assume responsibility for any modifications to promotion terms, product eligibility, or redemption requirements made by Sekisui Diagnostics.
- Customers are responsible for reviewing and following all redemption instructions provided by Sekisui Diagnostics.
- All promotional terms, conditions, and availability are determined by Sekisui Diagnostics and are subject to change without notice.
Reimbursement Information
This product may be eligible for reimbursement depending on current laws, policies, and individual circumstances. Please note that Rally Inc. does not handle, manage or process any reimbursements. All reimbursement matters are handled directly between you and the product manufacturer. To determine your eligibility and request reimbursement, please follow the manufacturer's reimbursement guidelines and instructions.
You can find more information on reimbursement details for this product below:
Link: https://www.codemap.com/sekisui/userhome.cfm.
Disclaimer:
Rally Inc. assumes no responsibility for the accuracy, completeness, or timeliness of the reimbursement information provided by the product manufacturer. Reimbursement policies are subject to change, and customers are encouraged to contact the product manufacturer directly for the most current information.
Manufacturer contact information for current product:
Sekisui Diagnostics:
https://sekisuidiagnostics.com/contact-us/.
EUA - Emergency Use Authorization
In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.Please see the Package Insert of this product for complete EUA information. You can find the document in the Education & Documents section.